AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $10,000.00 expenses · posted Oct 17, 2025

Lobbying activity 3

Medicare/Medicaid

Medicaid Reform

Health Issues

Sickle Cell policy Biotech innovation

Medical/Disease Research/Clinical Labs

Biotech Innovation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.